🏢 What kind of company is Aflac?

Aflac (AFL) is a global supplemental insurance company headquartered in Columbus, Georgia, United States, founded in 1955. Since its founding, the company has built a leading position in the supplemental insurance segment across its two core markets, Japan and the United States, with a focus on cancer insurance, medical supplemental insurance, and income protection insurance.

Its core products are cancer insurance, medical supplemental insurance, and income protection insurance, and it holds the No. 1 position in the Japanese supplemental insurance market. In the United States, it sells a variety of supplemental products primarily through workplace group channels, securing stable premium revenue in the life insurance segment.

Recent annual revenue ranks among the top tier of global supplemental insurance companies, with premium revenue from the Japan market accounting for the main share of revenue and showing a stable trend. The U.S. workplace group channel serves as a key growth pillar, contributing to the expansion of new policyholders, while investment income generated from insurance asset management plays a role in revenue diversification as supplementary earnings. Operating margins fluctuate based on the premium loss ratio and investment yield, with Japan market policy retention rates and new premium flows serving as the core drivers of margins.

📐 Aflac's market cap and corporate scale

Market capitalization stands at $64.8B, with 12,716명 employees.

As a leading supplemental insurance company within the top tier of global life insurers by market cap, Aflac maintains a market cap and asset base comparable to peer life insurers MET and PRU. Backed by stable premium free cash flow, the company has steadily continued its capital return policy through share buybacks and dividends, and its capital management structure is characterized by redistributing stable Japan premium revenue into U.S. business expansion and capital returns.

📈 Aflac outlook and stock price trends

Defending premium retention in the Japan market and expanding new policyholders in U.S. supplemental insurance are the key medium- to long-term variables. Growing demand for medical supplemental insurance driven by Japan's aging population, expansion of new products through the U.S. workplace group channel, and an improving interest income environment for insurance asset management are the main growth drivers. In the short term, potential volatility factors to monitor include the impact of yen-dollar exchange rate fluctuations on Japan revenue translation, pressure on investment yields in Japan's low-interest-rate environment, volatility in insurance claims loss ratios, and intensifying competition with peer life insurers.

• Growing demand for medical supplemental insurance driven by Japan's aging population
• Securing new policyholders through the U.S. workplace group channel
• Improving interest income environment for insurance asset management

⚔️ Aflac's core strengths and risks

Its No. 1 position in the Japan supplemental insurance market and stable premium cash flow are strengths, while exchange rate fluctuations and Japan's low-interest-rate investment environment are the core risks.

🔄 Aflac competitors and related (beneficiary) stocks

Direct competitors include fellow U.S. life insurance leader MET, comprehensive life and annuity player PRU, and UNM, often grouped alongside in workplace group supplemental insurance, along with LNC and GL. Related names compared in terms of capital markets and interest rate environment include CB in the broader P&C insurance industry, and TRV in comprehensive insurance and travel insurance.

✅ Aflac investor checklist

Key points to review when investing in Aflac. Japan premium retention rates, U.S. new policyholder acquisition, yen-dollar exchange rate trends, insurance asset investment yields, and capital return trends serve as the core short- and medium-term variables to monitor.

Yen-dollar exchange rate fluctuations and Japan's low-interest-rate investment environment are short-term margin risks. Loss ratio volatility driven by rising medical costs, intensifying competition across both Japan and U.S. markets, and pressure on insurance asset investment yields can also act as sources of volatility.

As a leading supplemental insurance company with a presence across both the Japan and U.S. markets, its strengths lie in stable premium cash flow and a consistent capital return policy. Given its exposure to exchange rate and interest rate variables, dollar-cost averaging and a long-term perspective are recommended.